Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04480502
Title ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma (ENVASARC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Tracon Pharmaceuticals Inc.
Age Groups: adult | child | senior
Covered Countries USA | GBR

No variant requirements are available.